Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI168080
- March 18, 2019
- Global
- 94 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the HPAPI (High Potency Active Pharmaceutical Ingredients) market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the HPAPI (High Potency Active Pharmaceutical Ingredients) market."
High potency active pharmaceutical ingredients are used in targeted therapeutics and show effective treatment even at extremely low concentration. These APIs are difficult to manufacture and require technological expertise and sophisticated manufacturing setup. HPAPI market currently accounts for a small portion of overall API market, however is a rapidly growing segment.
The global HPAPI (High Potency Active Pharmaceutical Ingredients) market is valued at 16600 million US$ in 2018 is expected to reach 32200 million US$ by the end of 2025, growing at a CAGR of 8.7% during 2019-2025.
This report focuses on HPAPI (High Potency Active Pharmaceutical Ingredients) volume and value at global level, regional level and company level. From a global perspective, this report represents overall HPAPI (High Potency Active Pharmaceutical Ingredients) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Alkermes
Cambrex
Dishman
Dr. ReddyS
Lonza
Novasep
Thermofisher Scientific
Pfizer
Merck
Teva Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Innovative HPAPI
Generic HPAPI
Segment by Application
Captive HPAPI
Merchant HPAPI
Table of Contents
Executive Summary
1 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Overview
1.1 Product Overview and Scope of HPAPI (High Potency Active Pharmaceutical Ingredients)
1.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Segment by Type
1.2.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Innovative HPAPI
1.2.3 Generic HPAPI
1.3 HPAPI (High Potency Active Pharmaceutical Ingredients) Segment by Application
1.3.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Comparison by Application (2014-2025)
1.3.2 Captive HPAPI
1.3.3 Merchant HPAPI
1.4 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market by Region
1.4.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Size
1.5.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue (2014-2025)
1.5.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production (2014-2025)
2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Competition by Manufacturers
2.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Market Share by Manufacturers (2014-2019)
2.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue Share by Manufacturers (2014-2019)
2.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Average Price by Manufacturers (2014-2019)
2.4 Manufacturers HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites, Area Served, Product Types
2.5 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Competitive Situation and Trends
2.5.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Concentration Rate
2.5.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Market Share by Regions
3.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Market Share by Regions
3.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue ...
| read more...
Related Reports
